Literature DB >> 11823106

Autosomal dominant epilepsy with febrile seizures plus with missense mutations of the (Na+)-channel alpha 1 subunit gene, SCN1A.

M Ito1, H Nagafuji, H Okazawa, K Yamakawa, T Sugawara, E Mazaki-Miyazaki, S Hirose, G Fukuma, A Mitsudome, K Wada, S Kaneko.   

Abstract

Evidence that febrile seizures have a strong genetic predisposition has been well documented. In families of probands with multiple febrile convulsions, an autosomal dominant inheritance with reduced penetrance is suspected. Four candidate loci for febrile seizures have been suggested to date; FEB1 on 8q13-q21, FEB2 on 19p, FEB3 on 2q23-q24, and FEB4 on 5q14-15. A missense mutation was identified in the voltage-gated sodium (Na(+))-channel beta 1 subunit gene, SCN1B at chromosome 19p13.1 in generalized epilepsy with the febrile seizures plus type 1 (GEFS+1) family. Several missense mutations of the (Na(+))-channel alpha 1 subunit (Nav1.1) gene, SCN1A were also identified in GEFS+2 families at chromosome 2q23-q24.3. The aim of this report is precisely to describe the phenotypes of Japanese patients with novel SCN1A mutations and to reevaluate the entity of GEFS+. Four family members over three generations and one isolated (phenotypically sporadic) case with SCN1A mutations were clinically investigated. The common seizure type in these patients was febrile and afebrile generalized tonic-clonic seizures (FS+). In addition to FS+, partial epilepsy phenotypes were suspected in all affected family members and electroencephalographically confirmed in three patients of two families. GEFS+ is genetically and clinically heterogeneous, and associated with generalized epilepsy and partial epilepsy as well. The spectrum of GEFS+ should be expanded to include partial epilepsies and better to be termed autosomal dominant epilepsy with febrile seizures plus (ADEFS+).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823106     DOI: 10.1016/s0920-1211(01)00313-8

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

Review 1.  Sodium channel mutations in epilepsy and other neurological disorders.

Authors:  Miriam H Meisler; Jennifer A Kearney
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 2.  Inherited disorders of voltage-gated sodium channels.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

3.  Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures.

Authors:  Thomas H Rhodes; Carlos G Vanoye; Iori Ohmori; Ikuo Ogiwara; Kazuhiro Yamakawa; Alfred L George
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

Review 4.  Sodium channel SCN1A and epilepsy: mutations and mechanisms.

Authors:  Andrew Escayg; Alan L Goldin
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

5.  Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A.

Authors:  Christoph Lossin; Thomas H Rhodes; Reshma R Desai; Carlos G Vanoye; Dao Wang; Sanda Carniciu; Orrin Devinsky; Alfred L George
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

6.  A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline.

Authors:  Kazusaku Kamiya; Makoto Kaneda; Takashi Sugawara; Emi Mazaki; Nami Okamura; Mauricio Montal; Naomasa Makita; Masaki Tanaka; Katsuyuki Fukushima; Tateki Fujiwara; Yushi Inoue; Kazuhiro Yamakawa
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

7.  Generalized epilepsy with febrile seizure plus (GEFS+) spectrum: Novel de novo mutation of SCN1A detected in a Malaysian patient.

Authors:  Emmilia H Tan; Abdul Aziz M Yusoff; Jafri M Abdullah; Salmi A Razak
Journal:  J Pediatr Neurosci       Date:  2012-05

8.  Haptoglobin HP2-2 genotype, alpha-thalassaemia and acute seizures in children living in a malaria-endemic area.

Authors:  Richard Idro; Thomas N Williams; Samson Gwer; Sophie Uyoga; Alex Macharia; Herbert Opi; Sarah Atkinson; Kathryn Maitland; Piet A Kager; Dominic Kwiatkowski; Brian G R Neville; Charles R J C Newton
Journal:  Epilepsy Res       Date:  2008-06-12       Impact factor: 3.045

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.